Home LiteratureArticle Details
PMID: 7439241 Published · ppublish English Clinical Trial Controlled Clinical Trial Journal Article

Maximal exercise power after a single dose of metoprolol and of slow-release metoprolol.

European journal of clinical pharmacology ·Vol. 18 ·No. 3 ·1980-10-00 ·Pages 225-9

Folgering H, van Bussel M

Abstract

The treatment of hypertension with a single daily-dose of a beta-blocker gives rise to high peak-plasma concentrations 1.5 h after ingestion. After slow release-preparations of beta-blockers, the peak concentrations are half those produced by the conventional preparation at the same oral dose. A frequently occurring side-effect of beta-blocker therapy is fatigue. In this study the effect of a single dose of metoprolol 300 mg, 200 mg, 200 mg slow-release and a placebo on maximal exercise power was tested in 6 healthy subjects, 1.5 h and 24 h after ingestion. Maximal exercise power was significantly reduced 1.5 h after ingestion of metoprolol 300 mg and 200 mg. No change was found 1.5 h after 200 mg of a slow-release preparation. The possible reasons for reduced maximal exercise power are discussed. It is concluded that use of a beta-blocker for the treatment of hypertension in a single daily-dose regimen may be a reason to prefer a slow-release preparation.

MeSH Terms
Adult Blood Pressure/drug effects Delayed-Action Preparations Heart Rate/drug effects Hemodynamics/drug effects Humans Male Metoprolol/administration & dosage,adverse effects,pharmacology Physical Exertion Propanolamines/pharmacology
Chemicals
Delayed-Action Preparations Propanolamines Metoprolol
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Folgering H
van Bussel M
References (14)
14 references, click to expand
  1. Effects of propranolol and metoprolol on haemodynamic and respiratory indices and on perceived exertion during exercise in hypertensive patients.
    Br Heart J. 1979 Jan;41(1):99-105 PMID: 371643
  2. Haemodynamic long-term effects of metoprolol at rest and during exercise in essential hypertension.
    Br J Clin Pharmacol. 1977 Apr;4(2):147-51 PMID: 861129
  3. Beta-blockers: once or three times a day?
    Br Med J. 1978 May 27;1(6124):1386-8 PMID: 348260
  4. Acute haemodynamic effects of metoprolol in hypertensive patients.
    Br J Clin Pharmacol. 1977 Feb;4(1):23-6 PMID: 843419
  5. Hemodynamic response to graded exercise after chronic beta-adrenergic blockade.
    J Appl Physiol Respir Environ Exerc Physiol. 1977 Feb;42(2):133-8 PMID: 838637
  6. Autonomic blocking drugs on circulatory adaptations at rest and during exercise in man. Pronethalol and poldine in long-term treatment.
    Acta Med Scand. 1968 Nov;184(5):347-52 PMID: 4389733
  7. Oxygen debt: effect of beta-adrenergic blockade on the lactacid and alactacid components.
    J Appl Physiol. 1969 Dec;27(6):813-6 PMID: 5353204
  8. The effects of propranolol and metoprolol on exercise responses in normal man [proceedings].
    Br J Clin Pharmacol. 1978 Nov;6(5):443P PMID: 728294
  9. Effects of propranolol on several physiological responses during orthostatic and exercise stress in healthy male subjects.
    Can J Physiol Pharmacol. 1971 Oct;49(10):867-72 PMID: 4400448
  10. Plasma levels and negative chronotropic effect of metoprolol following single doses of a conventional and sustained-release formulation.
    Eur J Clin Pharmacol. 1979 Mar 26;15(2):97-103 PMID: 436924
  11. Hemodynamic response to exercise after propranolol in normal subjects.
    Can J Physiol Pharmacol. 1966 May;44(3):465-74 PMID: 5914366
  12. Beta-blockade and muscle function.
    Lancet. 1978 Dec 16;2(8103):1318-9 PMID: 82832
  13. Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man.
    J Clin Invest. 1965 Nov;44(11):1745-53 PMID: 5843708
  14. Comparative bioavailability and effect studies on metoprolol administered as ordinary and slow-release tablets in single and multiple doses.
    Acta Pharmacol Toxicol (Copenh). 1975;36(Suppl 5):45-58 PMID: 1079687
Article Info
Journal
European journal of clinical pharmacology
Abbr.
Eur J Clin Pharmacol
ISSN
0031-6970
Published
1980-10-00
Pages
225-9
Language
English
Region
Germany
NLM ID
1256165
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com